Estrogen in breast cancer cells increases heparanase expression [100,102,103], and treatment of cholangiocarcinoma cells (bile duct cancer) with the estrogenic inducer 17β-estradiol upregulated heparanase mRNA [101]. This evidence concerns the gene HPSE and cholangiocarcinoma.